- EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines
- Spinraza: KEI asks DHHS Office of the Inspector General (OIG) to investigate a failure to disclose federal funding in patents
- Klobuchar Drug Importation Amendment Sees Votes Crossing the Aisle
- Groups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika Vaccine
- KEI initial opposition to U.S. Army grant of exclusive license to Sanofi on patents for Zika virus vaccine
- Colombia finalizes 44% price reduction of leukemia drug Glivec
- SCP25: Closing Statement of the Republic of South Africa
- Front page New York Times story explores Kite Pharma's profitable relationship with NIH regarding expensive cancer drug
- KEI Dec 9, 2016 comments to NIST on Bayh-Dole Act Regulations
- SCP25: South Africa’s Experience Related to the Topic of Access to Medicines
EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to MedicinesSubmitted by thiru on 23. January 2017 - 5:26
On the morning of Monday, 23 January 2017, India delivered the following intervention at the 140th session of the World Health Organization's Executive Board requesting the "explicit inclusion" of the United Nations Secretary-General's High-Level Panel Report in the "provisional agenda of the EB140 as a separate agenda item under item 8."
In making the case for the inclusion of the UN HLP in the WHO's Executive Board deliberations, India articulate the following:
Spinraza: KEI asks DHHS Office of the Inspector General (OIG) to investigate a failure to disclose federal funding in patentsSubmitted by James Love on 18. January 2017 - 13:41
KEI has asked the DHHS Office of the Inspector General (OIG) to investigate a failure to disclose federal funding of patents on nusinersen, a drug developed by Ionis Pharmaceuticals (formerly known as Isis Pharmacetuicals) with BioGen, and sold under the trade name Spinraza.
A copy of the 22 page letter to the OIG is available here:
At 11:06 P.M. on January 11, 2017, during the so-called “Vote-A-Rama”, the Senate considered an amendment put forward by Sen. Amy Klobuchar, D-Minn., and co-sponsored by Sen. Bernie Sanders, I-Vt., on the parallel importation of prescription drugs from Canada.
Groups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika VaccineSubmitted by James Love on 12. January 2017 - 7:50
KNOWLEDGE ECOLOGY INTERNATIONAL
FOR IMMEDIATE RELEASE
12 JANUARY 2017
CONTACT: Zack Struver, firstname.lastname@example.org, +1 (202) 332-2670
Groups Object to Army Proposal to Give Sanofi a Monopoly on Patents for Taxpayer-Funded Zika Vaccine
KEI initial opposition to U.S. Army grant of exclusive license to Sanofi on patents for Zika virus vaccineSubmitted by KEI Staff on 21. December 2016 - 14:23
December 21, 2016 -- KEI has filed comments with the U.S. Army Medical Research and Materiel Command (USAMRMC) on the proposed grant of an exclusive license to Sanofi on patents on a vaccine for Zika Virus.
The Colombian Ministry of Health has finalized the price reduction of Glivec, Novartis's +$47 billion leukemia drug, with a decrease in price from 368 pesos per milligram to 206.42 pesos per mg.
On Thursday, 15 December 2016, South Africa delivered this poignant, closing statement at WIPO's Standing Committee on the Law of Patents (SCP). Negotiations broke down on the issue of future work, as the European Union and Group B refused to permit discussions of the Report of the UN Secretary-General's High-Level Panel on Access to Medicines at future sessions of the SCP.
According to the WIPO website,
Front page New York Times story explores Kite Pharma's profitable relationship with NIH regarding expensive cancer drugSubmitted by Zack Struver on 20. December 2016 - 10:04
Matt Richtel and Andrew Pollack explore the complex policy issues involved with the pricing of products based on taxpayer-funded inventions and research in a front page New York Times story published today.
In November, NIST proposed to amend the regulations implementing the Bayh-Dole Act, 35 U.S.C. 200 et seq., which concerns intellectual property arising from federally-funded research, including 37 CFR sections 401 and 404. There were 15 comments, including a letter from KEI on December 9, 2016. EFF also provide comments. The other 13 comments to NIST were from Universities, associations or individuals taking the side of right-holders.
The KEI comments are available here.
On Wednesday, 14 December 2016, the delegation of South Africa delivered a comprehensive, moving account of South Africa's "journey in the quest to provide access to essential medicines" at WIPO's Standing Committee on the Law of Patents.
South Africa Access to Medicines: South Africa’s Experience Related to the Topic of Access to Medicines at the Standing Committee on the Laws of Patents
Madam Vice Chair,
On 7 December 2016, Justice Michael Kirby delivered the following keynote speech at the 39th Meeting of the UNAIDS Programme Coordinating Board during discussions on intellectual property and access to medicines. Justice Kirby served as a member of the United Nations Secretary-General's High-Level Panel on Access to Medicines.
PROGRAMME COORDINATING BOARD
39TH MEETING, WHO, GENEVA
AGENDA ITEM 6, 7 DECEMBER 2016
HIV/AIDS & SOLIDARITY - 30 YEARS ON*
On Tuesday, 13 December 2016, India delivered the following statement on behalf of the Asia and the Pacific Group during WIPO discussions on patents and health.
Statement by India on behalf of the Asia and the Pacific Group on the Agenda Item – Patents and Health - delivered by Dr. Sumit Seth, First Secretary (Economic Affairs) on 13 December 2016
India has the honour to deliver this statement on behalf of the Asia Pacific Group. The group would like to make 3 concrete points related to this agenda item
On Tuesday, 13 December 2016, the Republic of South Africa delivered the following statement during the WIPO Standing Committee on the Law of Patents (SCP) discussions on patents and health.
WIPO Standing Committee on the Law of Patents (SCP) 13 December 2016
South Africa aligns itself with the statement delivered by Nigeria on behalf of the Africa Group.
On Friday December 9, 2016, the Department of Commerce held a meeting at USPTO on "Developing the Digital Marketplace for Copyrighted Works" in order to "facilitate constructive, cross-industry dialogue among stakeholders about ways to promote a more robust and collaborative online marketplace for copyrighted works." Among the topics for discussion were "the potential for interoperability across digital registries and standards work in this field, and conside
On Monday, 12 December 2016, Knowledge Ecology International (KEI) delivered its opening statement to the 25th session of WIPO's Standing Committee on the Law of Patents (SCP).
KEI Opening Statement, for SCP 25
12 December 2016
KEI will discuss two topics. The first concerns government rights in patented inventions, when the government funds or partly funds the research.